Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

The approval marks a second indication for Zepbound, which was approved to treat overweight and obesity and uses the same active ingredient as the type 2 diabetes medication Mounjaro. “Too often, OSA ...